AXQ Capital’s NRX Pharmaceuticals NRXP Stock Holding History

AXQ Capital’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,211	Closed	-$70.7K	–	1236
2026 Q1	$70.7K	Buy	+33,211	New	+$67K	0.01%	907

Other funds holding NRXP

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AXQ Capital's NRXP Position: Q2 2026 in Review

AXQ Capital sold out of NRX Pharmaceuticals (NRXP) in Q2 2026, closing a stake of 33,211 shares — an estimated $70.7K sold.

AXQ Capital first reported a position in NRXP in Q1 2026 and held it in 1 quarter. The position peaked at $70.7K in Q1 2026. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

AXQ Capital reported no remaining NRX Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 33,211 NRX Pharmaceuticals shares in Q2 2026, an estimated $70.7K.
AXQ Capital first reported a position in NRX Pharmaceuticals in Q1 2026 and held it in 1 quarter.
AXQ Capital's NRX Pharmaceuticals position peaked at $70.7K in Q1 2026.
47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.